Xeroderma Pigmentosum (Kaposi's Disease) Summary

Networked: 1684 relevant articles (23 outcomes, 85 trials/studies) for this Disease

Key Drugs and Agents for Xeroderma Pigmentosum

1. Isotretinoin (Accutane) : 5 outcomes 2 studies in 13 results : FDA 6 Generic
   
2. DNA (Deoxyribonucleic Acid) : 3 outcomes 17 studies in 564 results : IBA
   
3. DNA Adducts : 2 outcomes 2 studies in 24 results : IBA
   
4. Retinoids : 2 outcomes 1 study in 9 results : IBA
   
5. Acitretin : 2 outcomes 1 study in 4 results : FDA 1
   
6. Codon (Codons) : 1 outcome 7 studies in 23 results : IBA
   
7. Platinum : 1 outcome 6 studies in 20 results : IBA
   
8. Bleomycin (Blenoxane) : 1 outcome 2 studies in 11 results : FDA 7 Generic
   
9. 4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide) : 1 outcome 1 study in 14 results : IBA
   
10. Etretinate : 1 outcome 1 study in 8 results : FDA 1
    

Diseases Related to Xeroderma Pigmentosum

1. Skin Neoplasms (Skin Cancer)
2. Neoplasms (Cancer)
3. Basal Cell Nevus Syndrome (Gorlin Syndrome)
4. Head and Neck Neoplasms (Head and Neck Cancer)
5. Squamous Cell Carcinoma (Epidermoid Carcinoma)

Key Therapies for Xeroderma Pigmentosum

1. Drug Therapy (Chemotherapy) : 2 outcomes 9 studies in 26 results
   
2. Chemoprevention : 2 outcomes 1 study in 6 results
   
3. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 1 outcome 1 study in 2 results
   
4. Transplants (Transplant) : 1 outcome in 20 results
   
5. Oral Administration : 1 outcome in 1 result